Latest News

Date Title Topic
03 Jun 2016 ESMO is Hiring!
02 Jun 2016 Everolimus for the Treatment of Advanced, Non-Functional Neuroendocrine Tumours of the Lung or Gastrointestinal Tract (RADIANT-4): a Randomised, Placebo-Controlled, Phase 3 Study Endocrine cancers
02 Jun 2016 FDA Approves New Diagnostic Imaging Agent to Detect Recurrent Prostate Cancer Genitourinary cancers - Imaging
01 Jun 2016 All European Scientific Articles to be Freely Accessible by 2020 Bioethics, legal and economic issues
31 May 2016 EMA Recommends to Refuse Marketing Authorisation for Ixazomib Haematologic malignancies - Anticancer agents & Biologic therapy
30 May 2016 Withdrawal of the EU Marketing Authorisation Application for Rociletinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
24 May 2016 Responsible and Effective Sharing of Cancer Genome Data Personalised medicine
23 May 2016 Unprecedented Progress in the Treatment of NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
20 May 2016 FDA Grants Accelerated Approval to Nivolumab for the Treatment of Hodgkin Lymphoma Haematologic malignancies - Cancer Immunology and Immunotherapy
19 May 2016 FDA Approves Atezolizumab for Treatment of Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
18 May 2016 Three Generations of Cancer Immunotherapies Cancer Immunology and Immunotherapy
13 May 2016 Can Regulators Influence the Affordability of Medicines? Bioethics, legal and economic issues
12 May 2016 Anti-Proliferative Effect and Predictive Biomarkers to Palbociclib in Early Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
12 May 2016 May 2016 - Image of the Month